These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30745840)

  • 21. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
    Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
    Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
    Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-depletion of cathepsin B and uPAR induces G0/G1 arrest in glioma via FOXO3a mediated p27 upregulation.
    Gopinath S; Malla RR; Gondi CS; Alapati K; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
    PLoS One; 2010 Jul; 5(7):e11668. PubMed ID: 20661471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
    He Z; Hu X; Liu W; Dorrance A; Garzon R; Houghton PJ; Shen C
    Oncotarget; 2017 Jun; 8(25):41422-41431. PubMed ID: 28507282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer.
    Fang Z; Lin A; Chen J; Zhang X; Liu H; Li H; Hu Y; Zhang X; Zhang J; Qiu L; Mei L; Shao J; Chen X
    Oncotarget; 2016 Nov; 7(47):78055-78068. PubMed ID: 27801665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer.
    Wu L; Yin L; Ma L; Yang J; Yang F; Sun B; Nianzeng X
    Aging (Albany NY); 2022 Oct; 14(19):7890-7905. PubMed ID: 36202136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
    Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
    Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
    Rahman MA; Amin AR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG; Shin DM
    Clin Cancer Res; 2013 Jul; 19(13):3416-28. PubMed ID: 23719266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
    Kang W; Tong JH; Chan AW; Zhao J; Wang S; Dong Y; Sin FM; Yeung S; Cheng AS; Yu J; To K
    Oncol Rep; 2014 Jun; 31(6):2579-86. PubMed ID: 24756820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SiRNA-Mediated
    Xue T; Wang L; Li Y; Song H; Chu H; Yang H; Guo A; Jiao J
    Int J Med Sci; 2019; 16(11):1510-1516. PubMed ID: 31673243
    [No Abstract]   [Full Text] [Related]  

  • 31. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
    Zhang M; Wang J; Yao R; Wang L
    Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells.
    Wu Z; Zhan Y; Wang L; Tong J; Zhang L; Lin M; Jin X; Jiang L; Lou Y; Qiu Y
    Biomed Pharmacother; 2020 Oct; 130():110556. PubMed ID: 32763815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
    Xia G; Wang H; Song Z; Meng Q; Huang X; Huang X
    J Exp Clin Cancer Res; 2017 Aug; 36(1):107. PubMed ID: 28797284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis.
    Ma J; Zhang F; Sun P
    Bioorg Med Chem; 2020 Feb; 28(3):115283. PubMed ID: 31902649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.
    Zhang H; Liu X; Warden CD; Huang Y; Loera S; Xue L; Zhang S; Chu P; Zheng S; Yen Y
    BMC Cancer; 2014 Sep; 14():664. PubMed ID: 25213022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Feb; 23(8):1539-48. PubMed ID: 14661056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.
    Song Y; Luo Q; Long H; Hu Z; Que T; Zhang X; Li Z; Wang G; Yi L; Liu Z; Fang W; Qi S
    Mol Cancer; 2014 Mar; 13():65. PubMed ID: 24650096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
    Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
    Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis.
    Zhang K; Hu S; Wu J; Chen L; Lu J; Wang X; Liu X; Zhou B; Yen Y
    Mol Cancer; 2009 Feb; 8():11. PubMed ID: 19250552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone and DNA damage encourage uterine cell proliferation and decidualization through up-regulating ribonucleotide reductase 2 expression during early pregnancy in mice.
    Lei W; Feng XH; Deng WB; Ni H; Zhang ZR; Jia B; Yang XL; Wang TS; Liu JL; Su RW; Liang XH; Qi QR; Yang ZM
    J Biol Chem; 2012 May; 287(19):15174-92. PubMed ID: 22403396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.